Company
VB Spine
Private spine-technology company formed in April 2025 when Viscogliosi Brothers acquired Stryker's former U.S. spinal-implants business. Developing ScolimiR-3D, a blood test to predict adolescent idiopathic scoliosis progression risk.
1 story
Regulatory News has published 1 story about VB Spine on 2 October 2026, sourced to the primary record — the regulator’s decision, the company’s filing or its own announcement. This page is generated from that coverage. Last updated 2 October 2026.
This page is generated from Regulatory News’ editorial coverage of VB Spine. It is not an advertisement.
On the record
- Company
- VB Spine, LLC
- Founded
- April 2025, when Viscogliosi Brothers acquired Stryker's U.S. spinal-implants business
- Regulator
- U.S. Food and Drug Administration (FDA)
- Latest milestone
- FDA Breakthrough Device Designation, ScolimiR-3D
Each line is taken from the most recent story of ours that states it.
Products in our coverage
Our coverage
